Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Closing the Gap: Examining Representation of Women in Ischemic Heart Disease Guideline Studies.

Journal of the American Heart Association·2026
Same author

Discrepancies between clinical and radiological assessment of complete remission of rectal cancer after neoadjuvant radiochemotherapy.

Langenbeck's archives of surgery·2026
Same author

Quantifying the Spatial Distribution of Series Resistance in Monolithic Perovskite/Silicon Tandem Solar Cells Using Voltage-Dependent Photoluminescence Imaging.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

High-resistance coils in E-cigarettes increase heavy metals leaching into aerosols to cause oxidants generation in human bronchial epithelial cells at air-liquid interface: A unique non-animal methodological approach on vaping studies.

NAM journal·2026
Same author

Editorial: Advances in non-clinical and translational studies: cutting-edge study designs, special technologies, routine pitfalls, background findings and control data.

Frontiers in veterinary science·2026
Same author

An Evaluation of the Long-term Impact of Gadolinium-based Contrast Agents on Sensory Nerves in Cynomolgus Monkeys.

Investigative radiology·2025

Related Experiment Video

Updated: Jul 22, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Inflammation as a Key Outcome Pathway in Particle Induced Effects in the Lung.

Paul J A Borm1,2, Dominique Lison3, Kevin Driscoll4

  • 1Heinrich Heine University of Dusseldorf, Dusseldorf, Germany.

Frontiers in Public Health
|June 13, 2022
PubMed
Summary

Inflammation is a critical factor in chronic diseases and particle toxicity. Persistent inflammation is now a key outcome in regulatory particle testing and animal inhalation studies.

Keywords:
cancergenomic instabilityhazard assessmentinflammationmacrophagesneutrophilsparticles

More Related Videos

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jul 22, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

  • Toxicology
  • Immunology
  • Environmental Health

Background:

  • Inflammation plays a central role in the pathology of chronic diseases, including particle-induced effects.
  • Persistent inflammation is a critical endpoint for regulatory standard-setting for poorly-soluble low-toxicity (PSLT) particles.
  • Current OECD-based sub-chronic animal inhalation testing protocols screen for inflammation.

Purpose of the Study:

  • To summarize key messages from the Particles & Health 2021 session on inflammation.
  • To provide insights into persistent inflammation as a protective or adverse response.
  • To discuss the regulatory impact and animal study outcomes related to inflammation.

Main Methods:

  • Review of presentations from leading experts in inflammation and particle toxicology.
  • Discussion of macrophage roles and human inflammatory pathways (asthma, COPD).
  • Analysis of expert workshop findings on PSLT particles and regulatory implications.
  • Examination of cell proliferation and pathologies in animal inhalation studies.

Main Results:

  • Recent insights into macrophage roles and human inflammatory pathways were presented.
  • The regulatory impact of using persistent inflammation as a key outcome was reviewed.
  • Animal study outcomes, including cell proliferation and pathologies, were emphasized for human response comparison.

Conclusions:

  • Inflammation is a crucial factor in particle-induced diseases and regulatory assessment.
  • Persistent inflammation is a key consideration in particle toxicity and inhalation testing.
  • Comparing human and animal responses requires careful evaluation of inflammation-associated outcomes in animal studies.